{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:20:39Z","timestamp":1777494039759,"version":"3.51.4"},"reference-count":93,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005497","name":"American Society for Pharmacology and Experimental Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpet.2025.103716","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:31:34Z","timestamp":1758299494000},"page":"103716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual sigma receptor\/dopamine transporter inhibition and the union of pharmacology and experimental psychology"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5652-3753","authenticated-orcid":false,"given":"Jonathan L.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1901\/jeab.1970.13-395","article-title":"Drugs in psychology: a commentary on Travis Thompson and Charles R. Schuster\u2019s Behavioral Pharmacology","volume":"13","author":"Dews","year":"1970","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.jpet.2025.103716_bib2","series-title":"Newsletter EBPS","first-page":"2","article-title":"Why did behavioural pharmacology develop so late?","author":"Dews","year":"1997"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"issue":"3-4","key":"10.1016\/j.jpet.2025.103716_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(83)90297-2","article-title":"Naltrexone fails to antagonize the \u03c3 effects of PCP and SKF 10,047 in the dog","volume":"92","author":"Vaupel","year":"1983","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103716_bib5","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1073\/pnas.78.9.5881","article-title":"Phencyclidine (angel dust)\/sigma \u201copiate\u201d receptor: visualization by tritium-sensitive film","volume":"78","author":"Quirion","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jpet.2025.103716_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00432758","article-title":"Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey","volume":"77","author":"Holtzman","year":"1982","journal-title":"Psychopharmacol (Berl)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(81)90352-6","article-title":"Psychotomimetic opioid binding: specific binding of [3H] SKF-10047 to etorphine-inaccessible sites in guinea-pig brain","volume":"75","author":"Su","year":"1981","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-3565(25)33330-6","article-title":"Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain","volume":"223","author":"Su","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"10.1016\/j.jpet.2025.103716_bib9","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1073\/pnas.80.21.6703","article-title":"Naloxone-inaccessible sigma receptor in rat central nervous system","volume":"80","author":"Tam","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.jpet.2025.103716_bib10","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1073\/pnas.83.22.8784","article-title":"1, 3-Di (2-[5-3H] tolyl) guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs","volume":"83","author":"Weber","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.jpet.2025.103716_bib11","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.jpet.2025.103716_bib12","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.1705154114","article-title":"Identification of the gene that codes for the \u03c32 receptor","volume":"114","author":"Alon","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.116.232728","article-title":"Blockade of cocaine or \u03c3 receptor agonist self-administration by subtype-selective \u03c3 receptor antagonists","volume":"358","author":"Katz","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103716_bib14","series-title":"Sigma Receptors: Chemistry, Cell Biology and Clinical Implications","author":"Matsumoto","year":"2007"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/jpet.103.051292","article-title":"Intracellular dynamics of sigma-1 receptors (sigma1 binding sites) in NG108-15 cells","volume":"306","author":"Hayashi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib17","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/s41467-017-02087-x","article-title":"The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission","volume":"8","author":"Sambo","year":"2017","journal-title":"Nat Commun"},{"issue":"3-4","key":"10.1016\/j.jpet.2025.103716_bib18","first-page":"187","article-title":"Delineating biochemical and functional properties of sigma receptors: emerging concepts","volume":"7","author":"Su","year":"1993","journal-title":"Crit Rev Neurobiol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103716_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/ph4060880","article-title":"A role for sigma receptors in stimulant self administration and addiction","volume":"4","author":"Katz","year":"2011","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.119.262790","article-title":"Distinct regulation of sigma (1) receptor multimerization by its agonists and antagonists in transfected cells and rat liver membranes","volume":"373","author":"Hong","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103716_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-12-420118-7.00009-3","article-title":"Sigma (\u03c3) receptors as potential therapeutic targets to mitigate psychostimulant effects","volume":"69","author":"Matsumoto","year":"2014","journal-title":"Adv Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103716_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/npp.2012.224","article-title":"Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists","volume":"38","author":"Hiranita","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2-3","key":"10.1016\/j.jpet.2025.103716_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(91)90355-T","article-title":"Selective sigma ligands block stimulant effects of cocaine","volume":"201","author":"Menkel","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-3565(25)38376-X","article-title":"Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine","volume":"266","author":"Witkin","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"10.1016\/j.jpet.2025.103716_bib26","doi-asserted-by":"crossref","first-page":"PL129","DOI":"10.1016\/0024-3205(92)90466-3","article-title":"Sigma. Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization","volume":"50","author":"Ujike","year":"1992","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2025.103716_bib27","first-page":"59","article-title":"Conditioned place preference","author":"Prus","year":"2009"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacol (Berl)"},{"issue":"13","key":"10.1016\/j.jpet.2025.103716_bib29","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/00001756-200009110-00011","article-title":"Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference","volume":"11","author":"Romieu","year":"2000","journal-title":"NeuroReport"},{"issue":"4","key":"10.1016\/j.jpet.2025.103716_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(01)00391-8","article-title":"Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade","volume":"26","author":"Romieu","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.jpet.2025.103716_bib31","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1523\/JNEUROSCI.23-09-03572.2003","article-title":"Sigma. Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward","volume":"23","author":"Romieu","year":"2003","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2011.02.017","article-title":"Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine","volume":"118","author":"Matsumoto","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103716_bib33","doi-asserted-by":"crossref","first-page":"546314","DOI":"10.1155\/2013\/546314","article-title":"N-Phenylpropyl-N\u2019-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the conditioned-rewarding properties of cocaine in mice","volume":"2013","author":"Sage","year":"2013","journal-title":"ISRN Pharmacol"},{"key":"10.1016\/j.jpet.2025.103716_bib34","series-title":"Handb Exp Pharmacol","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/164_2016_94","article-title":"A role for sigma receptors in stimulant self-administration and addiction","volume":"244","author":"Katz","year":"2017"},{"key":"10.1016\/j.jpet.2025.103716_bib35","series-title":"Assessment of Abuse Potential of Drugs: Guidance for Industry","year":"2017"},{"key":"10.1016\/j.jpet.2025.103716_bib36","series-title":"The Neuropharmacological Basis of Reward","first-page":"164","article-title":"Drugs as reinforcers: pharmacological and behavioral factors","author":"Katz","year":"1989"},{"issue":"7","key":"10.1016\/j.jpet.2025.103716_bib37","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addict Behav"},{"issue":"5-6","key":"10.1016\/j.jpet.2025.103716_bib38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/FBP.0b013e3283644d2e","article-title":"A translational pharmacology approach to understanding the predictive value of abuse potential assessments","volume":"24","author":"Horton","year":"2013","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neubiorev.2010.10.012","article-title":"The predictive validity of the rat self-administration model for abuse liability","volume":"35","author":"O\u2019Connor","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"10.1016\/j.jpet.2025.103716_bib40","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/sj.npp.1301323","article-title":"Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward","volume":"32","author":"Martin-Fardon","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"suppl 1","key":"10.1016\/j.jpet.2025.103716_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuropharm.2004.07.007","article-title":"Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats","volume":"47","author":"Barrett","year":"2004","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-001-0972-3","article-title":"Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats","volume":"160","author":"Schenk","year":"2002","journal-title":"Psychopharmacol (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/jpet.109.159236","article-title":"Reinforcing effects of \u03c3-receptor agonists in rats trained to self-administer cocaine","volume":"332","author":"Hiranita","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1124\/jpet.111.185025","article-title":"Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and \u03c3 receptors","volume":"339","author":"Hiranita","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"10.1016\/j.jpet.2025.103716_bib45","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1021\/jm9902943","article-title":"Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues","volume":"42","author":"Husbands","year":"1999","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-4159.1993.tb03174.x","article-title":"Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats","volume":"60","author":"Valchar","year":"1993","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(93)90381-Q","article-title":"Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate putamen","volume":"243","author":"Izenwasser","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.113.208264","article-title":"Preclinical efficacy of N-substituted Benztropine analogs as antagonists of methamphetamine self-administration in rats","volume":"348","author":"Hiranita","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.jpet.2025.103716_bib49","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1021\/acschemneuro.4c00589","article-title":"Preclinical profile of CM699 as a medication candidate for stimulant use disorder","volume":"16","author":"Hiranita","year":"2025","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2025.103716_bib51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.117.241109","article-title":"\u03c3 Receptor effects of N-substituted benztropine analogs: implications for antagonism of cocaine self-administration","volume":"362","author":"Hiranita","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"27","key":"10.1016\/j.jpet.2025.103716_bib53","doi-asserted-by":"crossref","first-page":"11250","DOI":"10.1074\/jbc.M116.774075","article-title":"The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats","volume":"292","author":"Hong","year":"2017","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jpet.2025.103716_bib54","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/cbdd.13841","article-title":"Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix\u2013helix interactions","volume":"97","author":"Xu","year":"2021","journal-title":"Chem Biol Drug Des"},{"issue":"42","key":"10.1016\/j.jpet.2025.103716_bib55","doi-asserted-by":"crossref","first-page":"32616","DOI":"10.1074\/jbc.M110.150565","article-title":"Membrane cholesterol modulates the outward-facing conformation of the dopamine transporter and alters cocaine binding","volume":"285","author":"Hong","year":"2010","journal-title":"J Biol Chem"},{"issue":"7474","key":"10.1016\/j.jpet.2025.103716_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature12533","article-title":"X-ray structure of dopamine transporter elucidates antidepressant mechanism","volume":"503","author":"Penmatsa","year":"2013","journal-title":"Nature"},{"issue":"8025","key":"10.1016\/j.jpet.2025.103716_bib57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","article-title":"Structure of the human dopamine transporter in complex with cocaine","volume":"632","author":"Nielsen","year":"2024","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.jpet.2025.103716_bib58","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1158\/0008-5472.CAN-07-1771","article-title":"Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines","volume":"67","author":"Palmer","year":"2007","journal-title":"Cancer Res"},{"issue":"3-4","key":"10.1016\/j.jpet.2025.103716_bib59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0376-8716(85)90061-4","article-title":"Drug discrimination studies","volume":"14","author":"Holtzman","year":"1985","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(03)01638-8","article-title":"Behavioral effects of rimcazole analogues alone and in combination with cocaine","volume":"468","author":"Katz","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib61","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.124.002239","article-title":"Effects of dual inhibition at dopamine transporter and \u03c3 receptors in the discriminative-stimulus effects of cocaine in male rats","volume":"391","author":"Hiranita","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103716_bib62","series-title":"Stimulus Properties of Drugs. Springer","author":"Thompson","year":"1971"},{"issue":"3-4","key":"10.1016\/j.jpet.2025.103716_bib63","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00213-002-1076-4","article-title":"Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons","volume":"163","author":"Ator","year":"2002","journal-title":"Psychopharmacol (Berl)"},{"issue":"4","key":"10.1016\/j.jpet.2025.103716_bib64","first-page":"159","article-title":"Drug discrimination and the analysis of private events","volume":"16","author":"Kangas","year":"2016","journal-title":"Behav Anal (Wash D C)"},{"key":"10.1016\/j.jpet.2025.103716_bib65","series-title":"Behavioral Pharmacology: The Current Status","first-page":"149","article-title":"Actions of opiate antagonists in relation to behavioral processes","author":"Morse","year":"1985"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(99)01717-5","article-title":"Satiety threshold: a quantitative model of maintained cocaine self-administration","volume":"839","author":"Tsibulsky","year":"1999","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-002-1366-x","article-title":"Variability of drug self-administration in rats","volume":"167","author":"Panlilio","year":"2003","journal-title":"Psychopharmacol (Berl)"},{"issue":"1-2","key":"10.1016\/j.jpet.2025.103716_bib68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0376-8716(97)01350-1","article-title":"Drug effects on food- and cocaine-maintained responding. IV: Effects of continuous infusions of cocaine","volume":"45","author":"Glowa","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s002130050618","article-title":"Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys","volume":"137","author":"Panlilio","year":"1998","journal-title":"Psychopharmacol (Berl)"},{"issue":"5","key":"10.1016\/j.jpet.2025.103716_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.npp.1300096","article-title":"Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol","volume":"28","author":"Negus","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib71","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/jpet.118.250498","article-title":"Dopamine transporter dynamics of N-substituted benztropine analogs with atypical behavioral effects","volume":"366","author":"Hong","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103716_bib73","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0022-3565(25)13038-3","article-title":"Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation","volume":"253","author":"Corwin","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.jpet.2025.103716_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.wnr.0000215767.94528.fb","article-title":"Intraparaventricular neuropeptide Y and ghrelin induce learned behaviors that report food deprivation in rats","volume":"17","author":"Jewett","year":"2006","journal-title":"NeuroReport"},{"key":"10.1016\/j.jpet.2025.103716_bib75","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jpet.2025.103716_bib76","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00213-018-4974-9","article-title":"Abuse liability of mitragynine assessed with a self-administration procedure in rats","volume":"235","author":"Yue","year":"2018","journal-title":"Psychopharmacol (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib77","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103716_bib78","series-title":"Behavioral Pharmacology","author":"Thompson","year":"1968"},{"key":"10.1016\/j.jpet.2025.103716_bib79","first-page":"1","article-title":"Behavioral mechanisms of drug dependence","volume":"Vol 4","author":"Thompson","year":"1984"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib80","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1901\/jeab.1984.42-511","article-title":"Rate dependency, behavioral mechanisms, and behavioral pharmacology","volume":"42","author":"Branch","year":"1984","journal-title":"J Exp Anal Behav"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib81","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jeab.80","article-title":"Reconsidering the concept of behavioral mechanisms of drug action","volume":"101","author":"Pitts","year":"2014","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.jpet.2025.103716_bib82","series-title":"Advances in Behavioral Pharmacology, Vol. 7","first-page":"13","article-title":"Effects of drugs on stimulus control of behavior under schedules of reinforcement","author":"Katz","year":"1990"},{"key":"10.1016\/j.jpet.2025.103716_bib83","series-title":"Experimental PsychopharmacologyContemporary","first-page":"393","article-title":"Measurement of drug effects on stimulus control","author":"Dykstra","year":"1987"},{"issue":"5","key":"10.1016\/j.jpet.2025.103716_bib84","doi-asserted-by":"crossref","first-page":"103575","DOI":"10.1016\/j.jpet.2025.103575","article-title":"Rate-dependent drug effects: history and contemporary implications","volume":"392","author":"Katz","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.jpet.2025.103716_bib85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/h0031246","article-title":"Nonparametric indexes for sensitivity and bias: computing formulas","volume":"75","author":"Grier","year":"1971","journal-title":"Psychol Bull"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib86","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(25)21042-4","article-title":"Effects of drugs on stimulus control of behavior. III. Analysis of effects of pentobarbital and d-amphetamine","volume":"246","author":"Katz","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103716_bib87","first-page":"1","article-title":"Drug self-administration: an analysis of the reinforcing effects of drugs","volume":"Vol 12","author":"Pickens","year":"1978"},{"issue":"11","key":"10.1016\/j.jpet.2025.103716_bib88","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1007\/s00213-018-5026-1","article-title":"Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats","volume":"235","author":"Highgate","year":"2018","journal-title":"Psychopharmacol (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2025.103716_bib89","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/npp.2014.238","article-title":"Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking","volume":"40","author":"Calipari","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jpet.2025.103716_bib90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"115","author":"Hursh","year":"2008","journal-title":"Psychol Rev"},{"issue":"12","key":"10.1016\/j.jpet.2025.103716_bib91","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1007\/s00213-019-05332-x","article-title":"A behavioral economic analysis of the effects of rimcazole on reinforcing effects of cocaine injection and food presentation in rats","volume":"236","author":"Job","year":"2019","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.jpet.2025.103716_bib92","series-title":"A Practical Guide to Pharmacological BiotechnologyLearning. Springer","first-page":"19","article-title":"Isolated tissues and organs","author":"Patra","year":"2019"},{"key":"10.1016\/j.jpet.2025.103716_bib93","series-title":"Learning","author":"Catania","year":"2013"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:32:42Z","timestamp":1762209162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022356525402298"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103716","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual sigma receptor\/dopamine transporter inhibition and the union of pharmacology and experimental psychology","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"103716"}}